BA
AGL icon

Bridgewater Associates’s Agilon Health AGL Stock Holding History

Bridgewater Associates’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-982
Closed -$46.6K – 671
2024
Q4 		$46.6K Sell
982
-3,710
-79% -$224K ﹤0.01% 691
2024
Q3 		$461K Sell
4,692
-4,800
-51% -$620K ﹤0.01% 697
2024
Q2 		$1.55M Sell
9,492
-1,763
-16% -$251K 0.01% 580
2024
Q1 		$1.72M Sell
11,255
-1,707
-13% -$284K 0.01% 513
2023
Q4 		$4.07M Buy
12,962
+776
+6% +$281K 0.02% 397
2023
Q3 		$5.41M Buy
12,186
+30
+0.2% +$13.6K 0.03% 347
2023
Q2 		$5.27M Buy
12,156
+1,748
+17% +$982K 0.03% 300
2023
Q1 		$6.18M Buy
10,408
+759
+8% +$425K 0.04% 275
2022
Q4 		$3.89M Sell
9,649
-4,273
-31% -$2M 0.02% 407
2022
Q3 		$8.15M Buy
13,922
+462
+3% +$277K 0.04% 287
2022
Q2 		$7.35M Buy
13,460
+2,746
+26% +$1.39M 0.03% 398
2022
Q1 		$6.79M Buy
10,714
+3,443
+47% +$1.77M 0.03% 384
2021
Q4 		$4.91M Buy
7,271
+928
+15% +$565K 0.03% 299
2021
Q3 		$4.16M Buy
+6,343
New +$5.42M 0.02% 317

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bridgewater Associates's AGL Position: Q1 2025 in Review

Bridgewater Associates sold out of Agilon Health (AGL) in Q1 2025, closing a stake of 982 shares — an estimated $46.6K sold.

Bridgewater Associates first reported a position in AGL in Q3 2021 and held it in 14 quarters. The position peaked at $8.15M in Q3 2022. 197 funds tracked by Wall St. Rank hold AGL as of Q1 2025.

  • Bridgewater Associates reported no remaining Agilon Health position as of Q1 2025 after selling out during the quarter.
  • Bridgewater Associates sold 982 Agilon Health shares in Q1 2025, an estimated $46.6K.
  • Bridgewater Associates first reported a position in Agilon Health in Q3 2021 and held it in 14 quarters.
  • Bridgewater Associates's Agilon Health position peaked at $8.15M in Q3 2022.
  • 197 funds tracked by Wall St. Rank held Agilon Health as of Q1 2025.

Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.